Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
  1. 2019
  2. Published
  3. 2018
  4. Published

    Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival

    Michaelsen, S. R., Urup, T., Olsen, L. R., Broholm, H., Lassen, U. & Poulsen, H. S., May 2018, In : Journal of Neuro-Oncology. 137, 3, p. 533-542 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    DNA Methylation Levels of the ELMO Gene Promoter CpG Islands in Human Glioblastomas

    Michaelsen, S. R., Aslan, D., Urup, T., Poulsen, H. S., Grønbæk, K., Broholm, H. & Kristensen, L. S., 28 Feb 2018, In : International Journal of Molecular Sciences. 19, 3, p. 679 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published
  7. Published
  8. Published

    Outcome of Bevacizumab Therapy in Patients with Recurrent Glioblastoma Treated with Angiotensin System Inhibitors

    Johansen, M. D., Urup, T., Holst, C. B., Christensen, I. J., Grunnet, K., Lassen, U., Friis, S. & Poulsen, H. S., 2018, In : Cancer Investigation. 36, 9-10, p. 512-519 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published
  10. Published
  11. Published

    VEGF-C Sustains VEGFR2 Activation under Bevacizumab Therapy and Promotes Glioblastoma Maintenance

    Michaelsen, S. R., Staberg, M., Pedersen, H., Jensen, K. E., Majewski, W., Broholm, H., Nedergaard, M. K., Meulengracht, C., Urup, T., Villingshøj, M., Lukacova, S., Skjøth-Rasmussen, J., Brennum, J., Kjær, A., Lassen, U., Stockhausen, M-T., Poulsen, H. S. & Hamerlik, P., 2018, In : Neuro-Oncology. 20, 11, p. 1462-74

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. 2017
  13. Published

    Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients

    Urup, T., Staunstrup, L. M., Michaelsen, S. R., Vitting-Seerup, K., Bennedbæk, M., Toft, A., Olsen, L. R., Jønson, L., Issazadeh-Navikas, S., Broholm, H., Hamerlik, P., Poulsen, H. S. & Lassen, U., 18 Apr 2017, In : B M C Cancer. 17, 1, p. e278

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published
  15. 2016
  16. Published

    A comprehensive profile of recurrent glioblastoma

    Campos, B., Olsen, L. R., Urup, T. & Poulsen, H. S., 10 Nov 2016, In : Oncogene. 35, 45, p. 5819-5825 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  17. Published

    Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients

    Urup, T., Michaelsen, S. R., Olsen, L. R., Toft, A., Christensen, I. J., Grunnet, K., Winther, O., Broholm, H., Kosteljanetz, M., Issazadeh-Navikas, S., Poulsen, H. S. & Lassen, U., Oct 2016, In : Molecular Oncology. 10, 8, p. 1160-1168

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    Angiotensinogen and HLA Class II Predict Bevacizumab Response in Recurrent Glioblastoma Patients

    Urup, T., Michaelsen, S. R., Olsen, L. R., Toft, A., Christensen, I. J., Grunnet, K., Winther, O., Broholm, H., Kosteljanetz, M., Issazadeh-Navikas, S., Poulsen, H. S. & Lassen, U., 2016.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  19. Published
  20. Published

    Effects of bevacizumab combination therapy on transcriptional changes in responding and non-responding recurrent glioblastoma patients

    Urup, T., Michaelsen, S. R., Staunstrup, L. M., Vitting-Seerup, K., Bennedbæk, M., Toft, A., Jønson, L., Broholm, H., Hamerlik, P., Poulsen, H. S. & Lassen, U., 2016.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  21. Published
  22. Published
  23. Published

    VEGF-C contributes to autocrine VEGF Receptor 2 signaling and cellular maintenance in glioblastoma

    Michaelsen, S. R., Nedergaard, M. K., Broholm, H., Bartkova, J., Staberg, M., Urup, T., Aghi, M., Lucacova, S., Villingshøj, M., Pedersen, P., Kjær, A., Perryman, L., Erler, J. T., Bartek, J., Lassen, U., Stockhausen, M., Poulsen, H. S. & Hamerlik, P., 2016.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  24. 2015
  25. Published
  26. Published
  27. 2014
  28. Published

    The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients

    Poulsen, H. S., Urup, T., Michaelsen, S. R., Staberg, M., Villingshøj, M. & Lassen, U., 26 Sep 2014, In : Cancer Management and Research. 6, p. 373-87 15 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  29. 2013
  30. Published

    Treatment with docetaxel and cisplatin in advanced adrenocortical carcinoma, a phase II study

    Urup, T., Pawlak, W. Z., Petersen, P. M., Pappot, H., Rørth, M. & Daugaard, G., 28 May 2013, In : B J C. 108, 10, p. 1994-7 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  31. 201
  32. Published

ID: 42241282